MUC1 isoform specific monoclonal antibody 6E6/2 detects preferential expression of the novel MUC1/Y protein in breast and ovarian cancer

International Journal of Cancer

Volumn 82, Issue 2, 1999, Pages 256-267

  Hartman, Mor Li ^a   Baruch, Amos ^a   Ron, Ilan ^a   Aderet, Yair ^a   Yoeli, Merav ^a   Sagi Assif, Orit ^a   Greenstein, Shuli ^a   Stadler, Yona ^a   Weiss, Mordechai ^a   Harness, Ella ^a   Yaakubovits, Margalit ^a   Keydar, Iafa ^a   Smorodinsky, Nechama I ^a   Wreschner, Daniel H ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 6E6 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN RECOGNITION; ARTICLE; BREAST CANCER; CONTROLLED STUDY; EPITOPE MAPPING; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION;

3T3 CELLS; ANIMALS; ANTIBODIES, MONOCLONAL; ASCITES; BREAST NEOPLASMS; CA-15-3 ANTIGEN; DNA, COMPLEMENTARY; EPITHELIAL CELLS; EPITOPES; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; PLEURAL EFFUSION, MALIGNANT; PROTEIN ISOFORMS; PROTEIN STRUCTURE, SECONDARY; RECOMBINANT FUSION PROTEINS; RNA SPLICING; RNA, MESSENGER; RNA, NEOPLASM; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0033050804     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990719)82:2<256::AID-IJC17>3.0.CO;2-C     Document Type: Article

References (26)

1. AICHER, B., LERCH, M.M., MULLER, T., SCHILLING, J. and ULLRICH, A., Cellular redistribution of protein tyrosine phosphatases LAR and PTP sigma by inducible proteolytic processing. J. Cell Biol., 138, 681-696 (1997).
2. BARUCH, A., HARTMAN, M., ZRIHAN-LICHT, S., GREENSTEIN, S., BURSTEIN, M., KEYDAR, I., WEISS, M. and WRESCHNER, D.H., Preferential expression and unique function of novel MUC1 tumor antigen isoform in human epithelial tumors. Int. J. Cancer, 71, 741-749 (1997).
3. BURCHELL, J., GENDLER, S., TAYOR-PAPADIMITRIOU, J., GIRLING, A., LEWIS, A., MILLIS, R. and LAMPORT, D., Development and characterization of breast cancer reactive monoclonal antibodies directed to the core protein of the human milk mucin. Cancer Res., 47, 5476-5482 (1987).
4. CERIANI, R.L., CHAN, C.M., BARATTA, F.S., OZZELLO, L., DEROSA, C.M. and HABIF, D.V., Levels of expression of breast epithelial mucin detected by monoclonal antibody BrE-3 in breast cancer prognosis. Int. J. Cancer, 51, 343-354 (1992).
5. FU, Y-X., WATSON, G.A., JIMENEZ, T.J., WANG, Y. and LOPEZ, D.M., Expansion of immunoregulatory macrophages by granulocyte-macrophage colony-stimulating factor derived from a murine mammary tumor. Cancer Res., 50, 227-234 (1990).
6. GENDLER, S.J., LANCASTER, C.A., TAYLOR-PAPADIMITRIOU, J., DUHIG, T., PEAT, N., BURCHELI, J., PEMBERTON, L., LALANI, E-N. and WILSON, D., Molecular cloning and expression of the human tumor associated polymorphic epithelial mucin PEM. J. biol. Chem., 265, 15286-15293 (1990).
7. HAYES, F.D. and 15 OTHERS. Prediction of prognosis in primary breast cancer by detection of a high molecular weight mucin-like antigen using monoclonal antibodies DF3, F36/22, and CU18: A cancer and leukemia group B study. J. clin. Oncol., 9, 1113-1123 (1991).
8. KEYDAR, I., CHOU, C.S., HAREUVENI, M., TSARFATY, I., SAHAR, E., SELZER, G., CHAITCHIK, S. and HIZI, A., Production and characterization of monoclonal antibodies identifying breast tumor associated antigens. Proc. nat. Acad. Sci. (Wash.), 86, 1362-1366 (1989).
9. KOHLER, G. and MILSTEIN, C., Continuous cultures of fused cells secreting antibody of predefined specificity. Nature (Lond), 256, 495-498 (1975).
10. LIGTENBERG, M.J.L., KRUIJSHAAR, L., BUIJS, F., VAN MEIJER, M., LITVINOV, S.V. and HILKENS, J., Cell associated episialin is a complex containing two proteins derived from a common precursor. J. biol. Chem., 267, 6171-6177 (1992).
11. LIGTENBERG, M.J.L., VOS, H.L., GENSSIEN, A.M. and HILKENS, J., Episialin a carcinoma associated mucin is generated by a polymorphic gene encoding splice variants with alternative amino termini. J. biol. Chem., 265, 15573-15578 (1990).
12. LINSLEY, P.S., BROWN, J.P., MAGNANI, J.L. and HORN, D., Monoclonal antibodies reactive with mucin glycoproteins found in sera from breast cancer patients. Cancer Res., 48, 2138-2148 (1988).
13. MACLEAN, G.D., REDDISH, M.A. and LONGENECKER, B.M., Prognostic significance of preimmunotherapy serum CA27.29 (MUC-1) mucin level after active specific immunotherapy of metastatic adenocarcinoma patients. J. Immunother., 20, 70-78 (1997).
14. MCGUCKIN, M.A., WALSH, M.D., HOHN, B.G., WARD, B.C. and WRIGHT, R.G., Prognostic significance of MUC1 epithelial mucin expression in breast cancer. Hum. Pathol., 26, 432-439 (1995).
15. OOSTERKAMP, H.M., SCHEINER, L., STEFANOVA, M.C., LLOYD, K.O. and FINSTAD, C.L., Comparison of MUC1 mucin expression in epithelial and non-epithelial cancer cell lines and demonstration of a new short variant form. Int. J. Cancer, 72, 87-94 (1997).
16. SERRA-PAGES, C., SAITO, H. and STREULI, M., Mutational analysis of proprotein processing, subunit association, and shedding of the LAR transmembrane protein tyrosine phosphatase. J. biol. Chem., 269, 23632-23641 (1994).
17. SPICER, A.P., DUHIG, T., CHILTON, B.S. and GENDLER, S.J., Analysis of mammalian MUC1 genes reveals potential functionally important domains. Mammalian Genome, 6, 885-888 (1995).
18. SWALLOW, D.M., GENDLER, S.J., GRIFFITHS, B., CORNEY, G., TAYLOR-PAPADIMITRIOU, J. and BRAMWELL, M.E., The human tumor-associated epithelial mucin proteins are coded by an expressed hypervariable gene locus PUM. Nature (Lond.), 328, 82-84 (1987).
19. TSARFATY, I., HAREUVENI, M., HOREV, J., ZARETSKY, J., WEISS, M., JELTSCH, J.M., GARNIER, J.M., LATHE, R., KEYDAR, I. and WRESCHNER, D.H., Isolation and characterization of an expressed hypervariable gene coding for a breast-cancer-associated antigen. Gene, 93, 313-318 (1990).
20. WESSELING, J., VAN DER VALK, S.W., VOS, H.L., SONNENBERG, A. and HILKENS, J., Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components. J. Cell Biol., 129, 255-265 (1995).
21. WRESCHNER, D.H. and 12 OTHERS, Isolation and characterization of full length cDNA coding for the H23 breast tumor associated antigen. In: M.A. Rich, J.C. Hager and I. Keydar (eds.), Breast cancer: progress in biology clinical management and prevention, pp. 41-59. Kluwer, Dordrecht (1989).
22. WRESCHNER, D.H., HAREUVENI, M., TSARFATY, I., SMORODINSKY, N., HOREV, J., ZARETSKY, J., KOTKES, P., WEISS, M., LATHE, R., DION, A.S. and KEYDAR, I., Human epithelial tumor antigen cDNA sequences- Differential splicing may generate multiple protein forms. Europ. J. Biochem., 189, 463-473 (1990).
23. XING, P.X., PRENZOSKA, J., QUELCH, K. and MCKENZIE, I.F.C., Second generation anti-MUC1 peptide monoclonal antibodies. Cancer Res., 52, 2310-2317 (1992).
24. YAMAMOTO, M., BHARTI, A., LI, Y. and KUFE, D., Interaction of the DF3/MUC1 breast carcinoma-associated antigen and beta-catenin in cell adhesion. J. biol. Chem., 272, 12492-12494 (1997).
25. ZRIHAN-LICHT, S., BARUCH, A., ELROY-STEIN, O., KEYDAR, I. and WRESCHNER, D.H., Tyrosine phosphorylation of the MUC1 breast cancer membrane proteins-cytokine receptor-like molecules. FEBS Lett., 356, 130-136 (1994a).
26. ZRIHAN-LICHT, S., VOS, H.L., BARUCH, A., ELROY-STEIN, O., SAGIV, D., KEYDAR, I., HILKENS, J. and WRESCHNER D.H., Characterization and molecular cloning of a novel MUC1 protein, devoid of tandem repeats, expressed in human breast cancer tissues. Europ. J. Biochem., 224, 787-795 (1994b).